Millipore Corporation (MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today awarded Dr. Jeanne Loring, Ph.D. a $150,000 grant for her work in stem cell research at The Scripps Research Institute of California. The funds will support Dr. Loring’s investigation of human pluripotent stem cells, which hold great promise for drug development and cell therapy.

“Through this grant, we are able to support innovative stem cell research projects that we believe may be the key to solving a number of human health issues,”said Martin Madaus, Chairman and CEO of Millipore Corporation. “We are pleased to offer this grant to Dr. Loring, who exemplifies the ground-breaking nature of this award through her extensive work in the stem cell field.”

Dr. Jeanne Loring is a distinguished researcher and founding director at The Scripps Research Institute in La Jolla, CA. Prior to joining Scripps in October 2007, she was on the faculty of the Burnham Institute for Medical Research as a principal investigator in January 2004 and was one of the principal architects of Burnham's successful human embryonic stem cell program.

“Stem cells are a crucial component to understanding and addressing diseases such as Alzheimer’s and Parkinson’s which impact millions of people,” says Dr. Loring. "It is imperative to continue our investigation in this field and I am pleased to have Millipore’s support.”

Dr. Loring is studying gene-regulating molecules known as microRNAs in relation to the ability of stem cells to self renew and to develop into diverse cell types. She has a B.S. in Molecular Biology from the University of Washington and a Ph.D. in Developmental Neurobiology from the University of Oregon.

This is the first major grant that Millipore has offered for stem cell research on the West Coast. The award is offered in increments of $50,000 a year for three years and is renewed each year at Millipore’s discretion. Madaus made the award presentation at the BIO 2008 Convention being held this week in San Diego, California The grant is funded through the Millipore Corporate Giving Program. Also present were senior executives and scientists from Millipore’s Temecula, California Bioscience headquarters.

As a leading provider of technologies, tools and services for the global Life Science industry, Millipore is committed to improving human health by supporting all facets of biomedical research. Millipore is investing significant resources in the advancement of stem cell research. In addition to the company’s own dedicated teams of scientists, many of whom have worked in leading human stem cell labs, Millipore has sponsored stem cell research and training programs around the world, from the Burnham Institute in San Diego, to the Australian Stem Cell Center in Melbourne and the Harvard Stem Cell Institute in Boston, Massachusetts.

About Millipore:

Millipore (MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. The expert scientists in our Life Sciences business unit understand the complexity of Life Science research and can support our customers in their most difficult challenges in cell biology, stem cells, protein research, and cell signaling. Millipore Corporation is an S&P 500 company with 6,000 employees in 47 countries worldwide. For more information, please contact Millipore Tech Service at 1-800-548-7853 or 951-676-8080 or visit www.millipore.com.

The Millipore Corporate Giving program seeks to contribute to the public good in ways that reflect our values as a company at the frontier of scientific innovation. One of our aims is to help Millipore employees make a positive difference in the world around them. We pursue our goals by offering grants in the areas of K–12 science education, bioscience research, and local community support and by funding a series of programs that encourage employee giving and volunteerism.

ADVANCING LIFE SCIENCE TOGETHERTM

Research. Development. Production.

About Scripps:

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Scripps Research is headquartered in La Jolla, California. It also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Currently operating from temporary facilities in Jupiter, Scripps Florida will move to its permanent campus by 2009.